Summary
This 8-K filing from DexCom, Inc. (DXCM) on May 6, 2005, primarily reports on their financial results for the quarter ended March 31, 2005. The company issued a press release on May 4, 2005, which is furnished as an exhibit to this report. This press release contains the details of their operational and financial performance for the period. Investors should note that this filing is furnished under Item 2.02 and is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities of that section and is not automatically incorporated by reference into other SEC filings. The key information for investors will be found within the content of the May 4, 2005 press release.
Key Highlights
- 1DexCom, Inc. (DXCM) filed an 8-K report on May 6, 2005.
- 2The report contains financial results for the quarter ended March 31, 2005.
- 3The financial results were announced via a press release dated May 4, 2005.
- 4The press release is furnished as Exhibit 99.01 to the 8-K filing.
- 5This filing is made pursuant to Item 2.02 of Form 8-K (Results of Operations and Financial Condition).
- 6The information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
- 7The Chief Financial Officer, Steven J. Kemper, signed the report on behalf of DexCom.
Frequently Asked Questions
The main purpose of this 8-K filing is to report DexCom, Inc.'s financial results for the quarter ended March 31, 2005, as announced in a press release on May 4, 2005.
The detailed financial results are contained within the press release dated May 4, 2005, which is furnished as Exhibit 99.01 to this 8-K report.
No, the information in this report, including the exhibit, is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it's not subject to the liabilities of that section.
No, the information contained in this filing is not incorporated by reference in any future or past filing of DexCom under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language.